Thirty Madison IPO
Thirty Madison is a digital health company that operates specialized telehealth brands focused on specific chronic conditions, including Keeps for hair loss, Nurx for reproductive health, and Cove for migraine treatment. The company combines telemedicine consultations with direct-to-consumer medication delivery and personalized treatment plans. Investors are attracted to Thirty Madison's vertical approach to digital health and its potential to scale across multiple therapeutic areas.
Key Facts
| Industry | Digital Health |
| Founded | 2017 |
| Headquarters | New York, NY |
| Employees | ~500 |
| Website | thirtymadison.com |
| Funding | Series B funding at $1B+ valuation. Total raised: $140M+ |
About Thirty Madison
Thirty Madison operates a portfolio of specialized telehealth brands that focus on chronic conditions requiring ongoing care and medication management. The company's brands include Keeps (hair loss), Cove (migraine), Nurture (dermatology), and Picnic (allergies), each providing end-to-end care including consultations, prescriptions, and medication delivery. Thirty Madison's approach involves creating condition-specific care experiences rather than general telehealth services, allowing for deeper specialization and better patient outcomes in each therapeutic area. The company leverages technology to streamline care delivery while maintaining clinical quality, and has built significant scale in managing chronic conditions that traditionally required frequent in-person visits.
IPO Status
Thirty Madison has not announced any plans for an initial public offering and continues to operate as a private company. The digital health platform has raised substantial venture capital funding to expand its portfolio of condition-specific brands and grow its telehealth services. The company has focused on building out its various health brands and expanding into new therapeutic areas through both organic growth and acquisitions. While the digital health sector has seen significant public market activity, Thirty Madison has not disclosed any confirmed details about IPO timing or valuation for a potential public offering.
Competitors
Frequently Asked Questions
Does Thirty Madison have a stock?
No, Thirty Madison has not had an IPO and remains a private company. The digital health platform has not announced any plans to go public.
When is the Thirty Madison IPO date?
There is no confirmed IPO date for Thirty Madison as the company has not announced plans to go public. No timeline has been provided for a potential public offering.
How can I buy Thirty Madison stock?
Thirty Madison stock cannot be purchased as the company is still private and not publicly traded. Shares are not available on public exchanges.
Stay Updated on the Thirty Madison IPO
Get real-time alerts when Thirty Madison files for an IPO, prices shares, or begins trading.
Get IPO Alerts